BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Zhang R, Xu Z, Wang Z. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. IJN 2022;Volume 17:909-25. [DOI: 10.2147/ijn.s349426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang D, Xu D, Chen W, Wu R, Wen Y, Liu A, Lin L, Lin X, Wang X. Fe-MnO(2) nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy. Biomed Pharmacother 2023;161:114431. [PMID: 36827713 DOI: 10.1016/j.biopha.2023.114431] [Reference Citation Analysis]
2 Chavda VP, Balar PC, Patel SB. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics 2023;7:128-41. [PMID: 36793354 DOI: 10.7150/ntno.80120] [Reference Citation Analysis]
3 Huang D, Xu D, Chen W, Wu R, Wen Y, Liu A, Lin L, Lin X, Wang X. Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy.. [DOI: 10.21203/rs.3.rs-2358203/v1] [Reference Citation Analysis]
4 Zhou F, Ma J, Zhu Y, Wang T, Yang Y, Sun Y, Chen Y, Song H, Huo X, Zhang J. The role and potential mechanism of O-Glycosylation in gastrointestinal tumors. Pharmacol Res 2022;:106420. [PMID: 36049664 DOI: 10.1016/j.phrs.2022.106420] [Reference Citation Analysis]
5 Bartos A, Iancu I, Ciobanu L, Onaciu A, Moldovan C, Moldovan A, Moldovan RC, Tigu AB, Stiufiuc GF, Toma V, Iancu C, Al Hajjar N, Stiufiuc RI. Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study. Nanomaterials 2022;12:2833. [DOI: 10.3390/nano12162833] [Reference Citation Analysis]
6 Li CH, Chang YC, Hsiao M, Chan MH. Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities. Pharmaceutics 2022;14:1282. [PMID: 35745854 DOI: 10.3390/pharmaceutics14061282] [Reference Citation Analysis]